Discovering and Delivering Compassionate, Coordinated Care
At UMass Memorial Cancer Center of Excellence in Worcester, MA, we work in partnership with the University of Massachusetts Medical School to research new treatments for cancer. UMass Memorial is at the forefront of some of the nation’s most promising research and treatment programs. Through our Cancer Center Clinical Research Office (CRO), we perform breakthrough research and clinical trials to improve treatment and your quality of life.
Pancreatic Cancer Trials Underway
ONCONOVA Therapeutics, Inc.
A Phase II/III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
INVESTIGATOR: Venu Bathini, MD
SPONSOR: ONCONOVA Therapeutics, Inc.
NCT01360853 at clinicaltrials.gov
Abraxis CA046
Abraxis: A Randomized Phase III Study of Weekly ABI-007 plus Gemcitabine vs Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of Pancreas
INVESTIGATOR: Venu Bathini, MD
SPONSOR: ABRAXIS BioScience
Abraxis CA046 at clinicaltrials.gov
Incyte Corporation
INCB 18424-262 A randomized Phase 2 study of Ruxolitinib Efficacy and safety in combination with Capecitabine for subjects with recurrent or treatment refractory metastatic Pancreatic cancer (The RECAP trial)
INVESTIGATOR: Venu Bathini, MD
SPONSOR: Incyte Corporation
Incyte Coporation - RECAP at clinicaltrials.gov
|
Learn more about research and other clinical trials underway at the UMass Memorial Cancer Center of Excellence.
Pancreatic Cancer Studies Recruiting:
To learn more about clinical trials and cancer research,
call 508-856-3216 or email cancer.research@umassmed.edu |